QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (38) Citing Articles via Google Scholar Google Scholar Articles by Adamson, D. C. Articles by Dawson, V. L. Search for Related Content PubMed PubMed Citation Articles by Adamson, D. C. Articles by Dawson, V. L.

 Previous Article  |  Next Article 

The Journal of Neuroscience, January 1, 1999, 19(1):64-71

Mechanisms and Structural Determinants of HIV-1 Coat Protein, gp41-Induced Neurotoxicity

D. Cory Adamson^{1, 2}, Kathy L. Kopnisky¹, Ted M. Dawson^{1, 2}, and Valina L. Dawson^{1, 2, 3}

Departments of ¹ Neurology, ² Neuroscience, and ³ Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287

Of the individuals with human immunodeficiency virus type 1 (HIV-1) infection, 20-30% will develop the neurological complication of HIV-associated dementia (HAD). The mechanisms underlying HAD are unknown; however, indirect immunologically mediated mechanisms are theorized to play a role. Recently, the HIV-1 coat protein gp41 has been implicated as a major mediator of HAD through induction of neurocytokines and subsequent neuronal cell death. Using primary mixed cortical cultures from neuronal nitric oxide synthase (NOS) null (nNOS^/) mice and immunological NOS null (iNOS^/) mice, we establish iNOS-derived NO as a major mediator of gp41 neurotoxicity. Neurotoxicity elicited by gp41 is markedly attenuated in iNOS^/ cultures compared with wild-type and nNOS^/ cultures. The NOS inhibitor L-nitroarginine methyl ester is neuroprotective in wild-type and nNOS^/ cultures, confirming the role of iNOS-derived NO in gp41 neurotoxicity. Confirming that iNOS^/ cultures lack iNOS, gp41 did not induce iNOS in iNOS^/ cultures, but it markedly induced iNOS in wild-type and nNOS^/ cultures. We elucidate the region of gp41 that is critical for iNOS induction and neuronal cell death by monitoring iNOS induction with overlapping peptides spanning gp41. We show that the N-terminal region of gp41, which we designate as the neurotoxic domain, induces iNOS protein activity and iNOS-dependent neurotoxicity at picomolar concentrations in a manner similar to recombinant gp41 protein. Our experiments suggest that gp41 is eliciting the induction of iNOS through potential cell surface receptors or binding sites because the induction of iNOS is dose dependent and saturable and occurs at physiologically relevant concentrations. These data confirm that the induction of iNOS by gp41 and the production of NO are primary mediators of neuronal damage and identify a neurotoxic domain of gp41 that may play an important role in HAD.

Key words: HIV-1; HIV-associated dementia; neurotoxicity; gp41; immunological nitric oxide synthase; nitric oxide

---

Copyright © 1999 Society for Neuroscience  0270-6474/99/19164-08$05.00/0

This article has been cited by other articles:

				H. Girouard, G. Wang, E. F. Gallo, J. Anrather, P. Zhou, V. M. Pickel, and C. Iadecola NMDA Receptor Activation Increases Free Radical Production through Nitric Oxide and NOX2 J. Neurosci., February 25, 2009; 29(8): 2545 - 2552. [Abstract] [Full Text] [PDF]

				W. Li, T. M. Malpica-Llanos, R. Gundry, R. J. Cotter, N. Sacktor, J. McArthur, and A. Nath Nitrosative stress with HIV dementia causes decreased L-prostaglandin D synthase activity Neurology, May 6, 2008; 70(19_Part_2): 1753 - 1762. [Abstract] [Full Text] [PDF]

				M. P. Heyes, R. J. Ellis, L. Ryan, M. E. Childers, I. Grant, T. Wolfson, S. Archibald, and T. L. Jernigan Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection Brain, May 1, 2001; 124(5): 1033 - 1042. [Abstract] [Full Text] [PDF]

				M. Sarter and M. Podell Preclinical psychopharmacology of AIDS-associated dementia: lessons to be learned from the cognitive psychopharmacology of other dementias J Psychopharmacol, May 1, 2000; 14(3): 197 - 204. [Abstract] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help